Understanding the causes of craniometaphyseal dysplasia
Pathogenic Mechanisms of Craniometaphyseal Dysplasia
This study is looking into how certain genetic changes cause craniometaphyseal dysplasia, a rare bone disorder that affects the growth of bones in the face and body, and it aims to find new ways to help manage the symptoms, like headaches and vision problems, so that people with this condition can have better treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-10878763 on NIH RePORTER |
What this research studies
This research investigates the underlying mechanisms of craniometaphyseal dysplasia (CMD), a rare bone disorder that leads to abnormal growth of craniofacial bones and long bones. By utilizing advanced mouse models and human stem cells, the study aims to uncover how specific genetic mutations contribute to the disease's progression and associated symptoms, such as headaches and vision loss. The research also explores potential therapeutic strategies to alleviate the debilitating effects of CMD, which often require invasive surgeries for correction.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with craniometaphyseal dysplasia, particularly those experiencing severe symptoms.
Not a fit: Patients with other unrelated bone disorders or those who do not have craniometaphyseal dysplasia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that improve the quality of life for patients with craniometaphyseal dysplasia.
How similar studies have performed: Previous research on genetic mechanisms of rare bone disorders has shown promise, indicating that this approach could yield valuable insights and potential breakthroughs.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Chen, I-Ping — University of Connecticut Sch of Med/dnt
- Study coordinator: Chen, I-Ping
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.